Global Thrombectomy Devices Market Size study, by Type, by Application, by End User and Regional Forecasts 2022-2028

  • Publish Date: Sep,2022
  • Report ID: QI037
  • Page : 200
  • Report Type : PDF (Email)
Global Thrombectomy Devices Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. Thrombectomy device is an intracoronary catheter with central aspiration lumen which is used in thrombus extraction. These are majorly used for minimizing the damage caused to blood vessels during surgical procedures and reducing blood loss. Thrombectomy devices have major applications in the treatment of acute myocardial infractions, peripheral arterial diseases, deep vein thrombosis, pulmonary embolism, and neurovascular thrombosis conditions. The market has experienced lucrative growth owing to the rising geriatric population in the forecast period. According to the World Bank in 2020, globally, the percentage of geriatric population above 65 is rising rapidly. In 2020 approximately 9.321 % population across the globe ages 65 and above. Also, in 2017 the percentage of geriatric population was about 8.648 % which increased rapidly and reached approximately 8.876 % by 2018. Whereas, in 2019 the global geriatric population ages 65 and above reached 9.102 %. The rising number of surgical centers and hospitals is another major factor surging the market growth. Whereas, rising demand for minimally invasive thrombectomy procedures and favorable growth activities by market players are other major factors boosting the market growth. However, the stringent government regulations impede market growth.

The key regions considered for the global Thrombectomy Devices market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market owing to the growing healthcare facilities, rising prevalence of neurological disorders, and growing number of thrombectomy devices. Whereas, Asia Pacific is projected to register the highest CAGR in the forecast period owing to the factors such as rising geriatric population, growing government insurance coverage and rising approval of new innovation embolization and thrombectomy products.

Major market players included in this report are:

Abbott Laboratories

AngioDynamics, Inc

Boston Scientific Group

Johnson and Johnson

Koninklijke Philips N.V.

Medtronic plc

Penumbra Inc.

Stryker Corporation

Teleflex Incorporated

Terumo Corporation

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:




Mechanical Thrombectomy

By Application:




By End-user:


Surgical Centers



By Region:

North America










Asia Pacific





South Korea


Latin America



Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Thrombectomy Devices Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers